NCT03742011 Offspring Born to Mothers With Polycystic Ovary Syndrome in Guangzhou Cohort Study
| NCT ID | NCT03742011 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Guangzhou Women and Children's Medical Center |
| Condition | PCOS |
| Study Type | OBSERVATIONAL |
| Enrollment | 2,000 participants |
| Start Date | 2012-02-01 |
| Primary Completion | 2025-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 2,000 participants in total. It began in 2012-02-01 with a primary completion date of 2025-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The Offspring Born to Mothers with Polycystic Ovary Syndrome in Guangzhou Cohort study (PCOS-BIG) was established to investigate the short- and long-term effects of intrauterine exposure to maternal PCOS on the health of offspring in Guangzhou, China. Data are collected regarding maternal PCOS subtypes, nursing, diet and education as well as health outcomes in their later life. Biological samples including blood and tissue samples are also collected from participants.
Eligibility Criteria
Inclusion Criteria: * Offspring born to women diagnosed with PCOS * Offspring born to women with \<20 weeks of gestation, intended to eventually deliver in Guangzhou Women and Children's Medical Center * Permanent residents or families intended to remain in Guangzhou for ≥3 years Exclusion Criteria: * None
Contact & Investigator
Xiu Qiu, PhD
PRINCIPAL INVESTIGATOR
Guangzhou Women and Children's Medical Center, China
Frequently Asked Questions
Who can join the NCT03742011 clinical trial?
This trial is open to participants of all sexes, up to 18 Years, studying PCOS. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT03742011 currently recruiting?
Yes, NCT03742011 is actively recruiting participants. Contact the research team at qxiu0161@163.com for enrollment information.
Where is the NCT03742011 trial being conducted?
This trial is being conducted at Guangzhou, China.
Who is sponsoring the NCT03742011 clinical trial?
NCT03742011 is sponsored by Guangzhou Women and Children's Medical Center. The principal investigator is Xiu Qiu, PhD at Guangzhou Women and Children's Medical Center, China. The trial plans to enroll 2,000 participants.